Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary Intervention
Clinical trial NCT04899479 · RECRUITING
Trial details
- NCT number
- NCT04899479
- Sponsor
- Samsung Medical Center
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-05
- Primary completion
- 2025-08-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.